American Research & Management Company Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
FedEx
FDX
|
+$407K |
| 2 |
Hingham Institution for Saving
HIFS
|
+$383K |
| 3 |
ExxonMobil
XOM
|
+$372K |
| 4 |
Alerian MLP ETF
AMLP
|
+$364K |
| 5 |
Chevron
CVX
|
+$242K |
Top Sells
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.93% |
| 2 | Consumer Staples | 15.6% |
| 3 | Healthcare | 14.62% |
| 4 | Financials | 10.59% |
| 5 | Miscellaneous | 8.89% |
Similar funds
American Research & Management Company's Q3 2019 Portfolio in Review
As of Q3 2019, American Research & Management Company held 351 positions worth $333M, down 0.52% from $334M the previous quarter. Its ten largest holdings account for 34% of the portfolio.
American Research & Management Company's Q3 2019 filing shows 8 new, 31 increased, 82 reduced and 17 closed positions. Its largest new stake was Toro Company: 125 shares worth $9K. The largest sale was BB&T Corporation Depositary Shares each representing 1/1,000th interest in a share of Series E Non-C, an estimated $992K.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 25% a quarter earlier, followed by Consumer Staples and Healthcare.
- American Research & Management Company's largest Q3 2019 buy was Toro Company: 125 shares worth $9K.
- American Research & Management Company added most to FedEx in Q3 2019, an estimated $407K increase.
- American Research & Management Company's biggest Q3 2019 reduction was Adobe, cutting an estimated $387K.
- American Research & Management Company fully exited BB&T Corporation Depositary Shares each representing 1/1,000th interest in a share of Series E Non-C in Q3 2019, selling an estimated $992K.
- American Research & Management Company's ten largest holdings make up 34% of its $333M portfolio in Q3 2019.
- American Research & Management Company opened 8 new positions and closed 17 in Q3 2019.
- American Research & Management Company's portfolio value fell 0.52% quarter-over-quarter to $333M.
Based on American Research & Management Company's 13F filing for Q3 2019, filed 31 Oct 2019.